<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39311394</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1096-9071</ISSN><JournalIssue CitedMedium="Internet"><Volume>96</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of medical virology</Title><ISOAbbreviation>J Med Virol</ISOAbbreviation></Journal><ArticleTitle>Reversion of neurovirulent mutations, recombination and high intra-host diversity in vaccine-derived poliovirus excreted by patients with primary immune deficiency.</ArticleTitle><Pagination><StartPage>e29918</StartPage><MedlinePgn>e29918</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/jmv.29918</ELocationID><Abstract><AbstractText>Patients with Primary immunodeficiency (PIDs) may be infected by Polioviruses (PVs), especially when vaccinated with live Oral Polio Vaccine before diagnosis. They may establish long-term shedding of divergent strains and may act as reservoirs of PV transmission. This study delved into the effect of the genetic evolution of complete PV genomes, from MHC class II-deficient patients, on the excretion duration and clinical outcomes. Stool samples from three PID patients underwent analysis for PV detection through inoculation on cell culture and real-time PCR, followed by VP1 partial sequencing and full genome sequencing using the Illumina technology. Our findings revealed a low number of mutations for one patient who cleared the virus, while two exhibited a high intra-host diversity favoring the establishment of severe outcomes. Neurovirulence-reverse mutations were detected in two patients, possibly leading to paralysis development. Furthermore, a recombination event, between type 3 Vaccine-Derived Poliovirus and Sabin-like1 (VDPV3/SL1), occurred in one patient. Our findings have suggested an association between intra-host diversity, recombination, prolonged excretion of the virus, and emergence of highly pathogenic strains. Further studies on intra-host diversity are crucial for a better understanding of the virus evolution as well as for the success of the Global Polio Eradication Initiative.</AbstractText><CopyrightInformation>© 2024 The Author(s). Journal of Medical Virology published by Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ben Salem</LastName><ForeName>Imene</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Laboratory of Clinical Virology, WHO Regional Reference Laboratory for Poliomyelitis and Measles for the EMR, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Virus, Hosts and Vectors (LR20IPT02), Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khemiri</LastName><ForeName>Haifa</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Laboratory of Clinical Virology, WHO Regional Reference Laboratory for Poliomyelitis and Measles for the EMR, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Virus, Hosts and Vectors (LR20IPT02), Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Drechsel</LastName><ForeName>Oliver</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Genome Competence Center (MF1), Robert Koch Institute, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arbi</LastName><ForeName>Marwa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Laboratory of Bioinformatics, Biomathematics and Biostatistics, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Böttcher</LastName><ForeName>Sindy</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>National Reference Laboratory for Poliomyelitis and Enteroviruses, Robert Koch Institute, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mekki</LastName><ForeName>Najla</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Laboratory of Transmission, Control and Immunology of Infections (LR11IPT02), Department of Immunobiology of infections, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ben Fraj</LastName><ForeName>Ilhem</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>National Bone Marrow Transplantation Center, Pediatric Hematology-Immunology Unit, Tunis, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Souiai</LastName><ForeName>Oussama</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Laboratory of Bioinformatics, Biomathematics and Biostatistics, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yahyaoui</LastName><ForeName>Mahrez</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>National Program of Immunization Basic Health Care Division, Ministry of Health, Tunis, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ben Farhat</LastName><ForeName>Essia</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>National Program of Immunization Basic Health Care Division, Ministry of Health, Tunis, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meddeb</LastName><ForeName>Zina</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Laboratory of Clinical Virology, WHO Regional Reference Laboratory for Poliomyelitis and Measles for the EMR, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Virus, Hosts and Vectors (LR20IPT02), Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Touzi</LastName><ForeName>Henda</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Laboratory of Clinical Virology, WHO Regional Reference Laboratory for Poliomyelitis and Measles for the EMR, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Virus, Hosts and Vectors (LR20IPT02), Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ben Mustapha</LastName><ForeName>Imene</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Laboratory of Transmission, Control and Immunology of Infections (LR11IPT02), Department of Immunobiology of infections, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>BenKahla</LastName><ForeName>Alia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Laboratory of Bioinformatics, Biomathematics and Biostatistics, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ouederni</LastName><ForeName>Monia</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>National Bone Marrow Transplantation Center, Pediatric Hematology-Immunology Unit, Tunis, Tunisia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, University of Tunis El Manar, Tunis, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barbouche</LastName><ForeName>Mohamed-R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Laboratory of Transmission, Control and Immunology of Infections (LR11IPT02), Department of Immunobiology of infections, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology, Immunology and Infectious Diseases, College of Medicine and Medical Sciences, Arabian Gulf University, Manama, Bahrain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diedrich</LastName><ForeName>Sabine</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>National Reference Laboratory for Poliomyelitis and Enteroviruses, Robert Koch Institute, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Triki</LastName><ForeName>Henda</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Laboratory of Clinical Virology, WHO Regional Reference Laboratory for Poliomyelitis and Measles for the EMR, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Virus, Hosts and Vectors (LR20IPT02), Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, University of Tunis El Manar, Tunis, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haddad-Boubaker</LastName><ForeName>Sondes</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-9705-4387</Identifier><AffiliationInfo><Affiliation>Laboratory of Clinical Virology, WHO Regional Reference Laboratory for Poliomyelitis and Measles for the EMR, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Virus, Hosts and Vectors (LR20IPT02), Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Program of Immunization Basic Health Care Division, Ministry of Health, Tunis, Tunisia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>811034</GrantID><Agency>European project PHINDaccess: Strengthening Omics data analysis capacities in pathogen-host interaction</Agency><Country /></Grant><Grant><GrantID>LR20IPT10</GrantID><Agency>Tunisian Ministry of Higher Education and Scientifc Research</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Med Virol</MedlineTA><NlmUniqueID>7705876</NlmUniqueID><ISSNLinking>0146-6615</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011055">Poliovirus Vaccine, Oral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="Y">Poliovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011055" MajorTopicYN="Y">Poliovirus Vaccine, Oral</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011995" MajorTopicYN="Y">Recombination, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="Y">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011051" MajorTopicYN="Y">Poliomyelitis</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005243" MajorTopicYN="Y">Feces</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017201" MajorTopicYN="Y">Virus Shedding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016679" MajorTopicYN="N">Genome, Viral</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014644" MajorTopicYN="N">Genetic Variation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000081207" MajorTopicYN="N">Primary Immunodeficiency Diseases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019143" MajorTopicYN="N">Evolution, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014774" MajorTopicYN="N">Virulence</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010802" MajorTopicYN="N">Phylogeny</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">intra‐host diversity</Keyword><Keyword MajorTopicYN="N">neurovirulent‐reverse mutations</Keyword><Keyword MajorTopicYN="N">recombination</Keyword><Keyword MajorTopicYN="N">vaccine‐derived poliovirus</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>12</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>12</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>7</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39311394</ArticleId><ArticleId IdType="doi">10.1002/jmv.29918</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Hsu CH, Kader M, Mahamud A, et al. Progress toward poliomyelitis eradication—Pakistan, January 2018–September 2019. MMWR Morb Mortal Wkly Rep. 2019;68(45):1029‐1033. doi:10.15585/mmwr.mm6845a5</Citation></Reference><Reference><Citation>Manyanga D, Masvikeni B, Daniel F. The experiences of using polio outbreak simulation exercises to strengthen national outbreaks preparedness and response plans in sub‐Saharan Africa. Pan Afr Med J. 2020;36(1):340.</Citation></Reference><Reference><Citation>CDC‐Centers for Disease Control and Prevention. Update on vaccine‐derived polioviruses worldwide, July 2009–March 2011. MMWR Morb Mortal Wkly Rep. 2011;60:846‐850.</Citation></Reference><Reference><Citation>Mohanty MC, Madkaikar MR, Desai M, et al. Natural clearance of prolonged VDPV infection in a child with primary immunodeficiency disorder. Front Immunol. 2019;10:1567. doi:10.3389/fimmu.2019.01567</Citation></Reference><Reference><Citation>Guo J, Bolivar‐Wagers S, Srinivas N, Holubar M, Maldonado Y. Immunodeficiency‐related vaccine‐derived poliovirus (iVDPV) cases: a systematic review and implications for polio eradication. Vaccine. 2015;33(10):1235‐1242. doi:10.1016/j.vaccine.2015.01.018</Citation></Reference><Reference><Citation>Kew OM, Wright PF, Agol VI, et al. Circulating vaccine‐derived polioviruses: current state of knowledge. Bull World Health Organ. 2004;82:16‐23.</Citation></Reference><Reference><Citation>Savolainen‐Kopra C, Blomqvist S. Mechanisms of genetic variation in polioviruses. Rev Med Virol. 2010;20(6):358‐371. doi:10.1002/rmv.663</Citation></Reference><Reference><Citation>Kirkegaard K, Baltimore D. The mechanism of RNA recombination in poliovirus. Cell. 1986;47(3):433‐443. doi:10.1016/0092-8674(86)90600-8</Citation></Reference><Reference><Citation>Rousset D, Rakoto‐Andrianarivelo M, Razafindratsimandresy R, et al. Recombinant vaccine–derived poliovirus in Madagascar. Emerging Infect Dis. 2003;9(7):885‐887. doi:10.3201/eid0907.020692</Citation></Reference><Reference><Citation>Pavlov DN, van Zyl WB, van Heerden J, et al. Prevalence of vaccine‐derived polioviruses in stools of immunodeficient children in South Africa. J Appl Microbiol. 2006;101(6):1367‐1379. doi:10.1111/j.1365-2672.2006.03020.x</Citation></Reference><Reference><Citation>Minor P. Vaccine‐derived poliovirus (VDPV): impact on poliomyelitis eradication. Vaccine. 2009;27(20):2649‐2652. doi:10.1016/j.vaccine.2009.02.071</Citation></Reference><Reference><Citation>Kitamura K, Shimizu H. Outbreaks of circulating vaccine‐derived poliovirus in the world health organization Western pacific region, 2000–2021. Jpn J Infect Dis. 2022;75(5):JJID.2022.312. doi:10.7883/yoken.JJID.2022.312</Citation></Reference><Reference><Citation>Macklin G, Diop OM, Humayun A, et al. Update on immunodeficiency‐associated vaccine‐derived polioviruses—worldwide, July 2018–December 2019. MMWR Morb Mortal Wkly Rep. 2020;69(28):913‐917. doi:10.15585/mmwr.mm6928a4</Citation></Reference><Reference><Citation>Chouikha A, Rezig D, Driss N, et al. Circulation and molecular epidemiology of enteroviruses in paralyzed, immunodeficient and healthy individuals in Tunisia, a country with a polio‐free status for decades. Viruses. 2021;13(3):380. doi:10.3390/v13030380</Citation></Reference><Reference><Citation>Haddad‐Boubaker S, Ould‐Mohamed‐Abdallah MV, Ben‐Yahia A, Triki H. Recombinaison génétique chez le poliovirus vaccinal: étude comparative chez les souches excrétées en cours de vaccination par le vaccin poliomyélitique oral et les souches circulantes. Pathol Biol. 2010;58(6):420‐425. doi:10.1016/j.patbio.2009.01.004</Citation></Reference><Reference><Citation>Haddad‐Boubaker S, ben Yahia A, Bahri O, et al. Genetic features of polioviruses isolated in Tunisia, 1991–2006. J Clin Virol. 2008;41(2):81‐86. doi:10.1016/j.jcv.2007.10.002</Citation></Reference><Reference><Citation>Driss N, Mellouli F, ben Yahia A, et al. Sequential asymptomatic enterovirus infections in a patient with major histocompatibility complex class II primary immunodeficiency. J Clin Microbiol. 2014;52(9):3486‐3489. doi:10.1128/JCM.01122-14</Citation></Reference><Reference><Citation>Driss N, Ben‐Mustapha I, Mellouli F, et al. High susceptibility for enterovirus infection and virus excretion features in Tunisian patients with primary immunodeficiencies. Clin Vaccine Immunol. 2012;19(10):1684‐1689. doi:10.1128/CVI.00293-12</Citation></Reference><Reference><Citation>Global Polio Eradication Initiative Updates on ITD molecular testing. Global Polio Eradication Initiative; 2020. https://polioeradication.org/wp-content/uploads/2020/01/GP2-Updates-on-ITD-molecular-testing.pdf</Citation></Reference><Reference><Citation>Steven Oberste M, Pallansch MA. Enteroviruses and parechoviruses. Clinical virology manual. ASM Press; 2016:277‐292. doi:10.1128/9781555819156.ch20</Citation></Reference><Reference><Citation>Kilpatrick DR, Iber JC, Chen Q, et al. Poliovirus serotype‐specific VP1 sequencing primers. J Virol Methods. 2011;174(1‐2):128‐130. doi:10.1016/j.jviromet.2011.03.020</Citation></Reference><Reference><Citation>Nextera DNA Library Prep Reference Guide (15027987). https://support.illumina.com/content/dam/illumina-support/documents/documentation/chemistry_documentation/samplepreps_nextera/nexteradna/nextera-dna-library-prep-reference-guide-15027987-01.pdf</Citation></Reference><Reference><Citation>Chen S, Zhou Y, Chen Y, Gu J. fastp: an ultra‐fast all‐in‐one FASTQ preprocessor. Bioinformatics. 2018;34(17):i884‐i890. doi:10.1093/bioinformatics/bty560</Citation></Reference><Reference><Citation>Li H. Aligning sequence reads, clone sequences and assembly contigs with BWA‐MEM. arXiv preprint arXiv:1303.3997. 2013.</Citation></Reference><Reference><Citation>Grubaugh ND, Gangavarapu K, Quick J, et al. An amplicon‐based sequencing framework for accurately measuring intrahost virus diversity using PrimalSeq and iVar. Genome Biol. 2019;20(1):8. doi:10.1186/s13059-018-1618-7</Citation></Reference><Reference><Citation>Lole KS, Bollinger RC, Paranjape RS, et al. Full‐length human immunodeficiency virus type 1 genomes from subtype C‐infected seroconverters in India, with evidence of intersubtype recombination. J Virol. 1999;73(1):152‐160. doi:10.1128/JVI.73.1.152-160.1999</Citation></Reference><Reference><Citation>Kumar S, Stecher G, Tamura K. MEGA7: molecular evolutionary genetics analysis version 7.0 for bigger datasets. Mol Biol Evol. 2016;33(7):1870‐1874. doi:10.1093/molbev/msw054</Citation></Reference><Reference><Citation>Lefort V, Longueville J‐E, Gascuel O. SMS: smart model selection in PhyML. Mol Biol Evol. 2017;34(9):2422‐2424. doi:10.1093/molbev/msx149</Citation></Reference><Reference><Citation>McKenna A, Hanna M, Banks E, et al. The genome analysis toolkit: a MapReduce framework for analyzing next‐generation DNA sequencing data. Genome Res. 2010;20(9):1297‐1303. doi:10.1101/gr.107524.110</Citation></Reference><Reference><Citation>Wickham H. ggplot2. Springer New York; 2009. doi:10.1007/978-0-387-98141-3</Citation></Reference><Reference><Citation>Westrop GD, Wareham KA, Evans DM, et al. Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine. J Virol. 1989;63(3):1338‐1344. doi:10.1128/jvi.63.3.1338-1344.1989</Citation></Reference><Reference><Citation>Nomoto A, Omata T, Toyoda H, et al. Complete nucleotide sequence of the attenuated poliovirus Sabin 1 strain genome. Proc Natl Acad Sci USA. 1982;79(19):5793‐5797. doi:10.1073/pnas.79.19.5793</Citation></Reference><Reference><Citation>Gong P, Peersen OB. Structural basis for active site closure by the poliovirus RNA‐dependent RNA polymerase. Proc Natl Acad Sci USA. 2010;107(52):22505‐22510. doi:10.1073/pnas.1007626107</Citation></Reference><Reference><Citation>Stanway G, Hughes PJ, Mountford RC, et al. Comparison of the complete nucleotide sequences of the genomes of the neurovirulent poliovirus P3/Leon/37 and its attenuated Sabin vaccine derivative P3/Leon 12a1b. Proc Natl Acad Sci USA. 1984;81(5):1539‐1543. doi:10.1073/pnas.81.5.1539</Citation></Reference><Reference><Citation>Pollard SR, Dunn G, Cammack N, Minor PD, Almond JW. Nucleotide sequence of a neurovirulent variant of the type 2 oral poliovirus vaccine. J Virol. 1989;63(11):4949‐4951. doi:10.1128/jvi.63.11.4949-4951.1989</Citation></Reference><Reference><Citation>Christodoulou C, Colbere‐Garapin F, Macadam A, et al. Mapping of mutations associated with neurovirulence in monkeys infected with Sabin 1 poliovirus revertants selected at high temperature. J Virol. 1990;64(10):4922‐4929. doi:10.1128/jvi.64.10.4922-4929.1990</Citation></Reference><Reference><Citation>Fayaz F, Sharafian S, Tavakol M. Incidence of poliovirus infection in patients with severe combined immunodeficiency (SCID). Immunol Genet J. 2022;4:95‐100. doi:10.18502/igj.v4i2.9985</Citation></Reference><Reference><Citation>Bittles AH, Black ML. Consanguineous marriage and human evolution. Annu Rev Anthropol. 2010;39(1):193‐207. doi:10.1146/annurev.anthro.012809.105051</Citation></Reference><Reference><Citation>elHawary RE, Mauracher AA, Meshaal SS, et al. MHC‐II deficiency among Egyptians: novel mutations and unique phenotypes. J Allergy Clin Immunol Pract. 2019;7(3):856‐863. doi:10.1016/j.jaip.2018.07.046</Citation></Reference><Reference><Citation>Shaghaghi M, Shahmahmoodi S, Nili A, et al. Vaccine‐derived poliovirus infection among patients with primary immunodeficiency and effect of patient screening on disease outcomes, Iran. Emerging Infect Dis. 2019;25(11):2005‐2012. doi:10.3201/eid2511.190540</Citation></Reference><Reference><Citation>Mohanty MC, Madkaikar MR, Desai M, et al. Poliovirus excretion in children with primary immunodeficiency disorders, India. Emerging Infect Dis. 2017;23(10):1664‐1670. doi:10.3201/eid2310.170724</Citation></Reference><Reference><Citation>Shaghaghi M, Shahmahmoodi S, Abolhassani H, et al. Vaccine‐Derived polioviruses and children with primary immunodeficiency, Iran, 1995–2014. Emerging Infect Dis. 2016;22(10):1712‐1719. doi:10.3201/eid2210.151071</Citation></Reference><Reference><Citation>Combelas N, Holmblat B, Joffret M‐L, Colbère‐Garapin F, Delpeyroux F. Recombination between poliovirus and coxsackie A viruses of species C: a model of viral genetic plasticity and emergence. Viruses. 2011;3(8):1460‐1484. doi:10.3390/v3081460</Citation></Reference><Reference><Citation>Yang C‐F, Chen H‐Y, Jorba J, et al. Intratypic recombination among lineages of type 1 vaccine‐derived poliovirus emerging during chronic infection of an immunodeficient patient. J Virol. 2005;79(20):12623‐12634. doi:10.1128/JVI.79.20.12623-12634.2005</Citation></Reference><Reference><Citation>Pfeiffer JK. Innate host barriers to viral trafficking and population diversity. Adv Virus Res. 2010;77:85‐118. doi:10.1016/B978-0-12-385034-8.00004-1</Citation></Reference><Reference><Citation>Jary A, Leducq V, Malet I, et al. Evolution of viral quasispecies during SARS‐CoV‐2 infection. Clin Microbiol Infect. 2020;26(11):1560.e1‐1560.e4. doi:10.1016/j.cmi.2020.07.032</Citation></Reference><Reference><Citation>Martín J, Dunn G, Hull R, Patel V, Minor PD. Evolution of the sabin strain of type 3 poliovirus in an immunodeficient patient during the entire 637‐Day period of virus excretion. J Virol. 2000;74(7):3001‐3010. doi:10.1128/JVI.74.7.3001-3010.2000</Citation></Reference><Reference><Citation>alKhatib HA, Benslimane FM, Elbashir IE, et al. Within‐host diversity of SARS‐CoV‐2 in COVID‐19 patients with variable disease severities. Front Cell Infect Microbiol. 2020;10:575613. doi:10.3389/fcimb.2020.575613</Citation></Reference><Reference><Citation>Voloch CM, da Silva Francisco Jr. R, de Almeida LGP, et al. Intra‐host evolution during SARS‐CoV‐2 prolonged infection. Virus Evol. 2021;7(2):veab078. doi:10.1093/ve/veab078</Citation></Reference><Reference><Citation>Karamitros T, Papadopoulou G, Bousali M, Mexias A, Tsiodras S, Mentis A. SARS‐CoV‐2 exhibits intra‐host genomic plasticity and low‐frequency polymorphic quasispecies. J Clin Virol. 2020;131:104585. doi:10.1016/j.jcv.2020.104585</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>